Piper Jaffray’s Top Pick For 2015: Bluebird Bio Inc (BLUE)

December 9, 2014 9:41 PM

13 0

Analyst Joshua Schimmer doubled his target price for bluebird’s stock, from $52 to $112, and maintained his Overweight rating

bluebird bio Inc (NASDAQ:BLUE) stock has surged 58.56% after the biotech firm’s LentiGlobin BB305 drug allowed patients with beta thalassemia to produce hemoglobin, removing the need for blood transfusion. The results were presented at a conference held by American Society of Hematology (ASH) in San...

Read more

To category page